Literature DB >> 16288016

The differential effects of mutant p53 alleles on advanced murine lung cancer.

Erica L Jackson1, Kenneth P Olive, David A Tuveson, Roderick Bronson, Denise Crowley, Michael Brown, Tyler Jacks.   

Abstract

We report a direct comparison of the differential effects of individual p53 mutations on lung tumor growth and progression, and the creation of a murine model of spontaneous advanced lung adenocarcinoma that closely recapitulates several aspects of advanced human pulmonary adenocarcinoma. We generated compound conditional knock-in mice with mutations in K-ras combined with one of three p53 alleles: a contact mutant, a structural mutant, or a null allele. p53 loss strongly promoted the progression of K-ras-induced lung adenocarcinomas, yielding a mouse model that is strikingly reminiscent of advanced human lung adenocarcinoma. The influence of p53 loss on malignant progression was observed as early as 6 weeks after tumor initiation. Furthermore, we found that the contact mutant p53R270H, but not the structural mutant p53R172H, acted in a partially dominant-negative fashion to promote K-ras-initiated lung adenocarcinomas. However, for both mutants, loss-of-heterozygosity occurred uniformly in advanced tumors, highlighting a residual tumor-suppressive function conferred by the remaining wild-type allele of p53. Finally, a subset of mice also developed sinonasal adenocarcinomas. In contrast to the lung tumors, expression of the point-mutant p53 alleles strongly promoted the development of sinonasal adenocarcinomas compared with simple loss-of-function, suggesting a tissue-specific gain-of-function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288016     DOI: 10.1158/0008-5472.CAN-05-2193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  292 in total

Review 1.  Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets.

Authors:  Matthias Drosten; Carmen Guerra; Mariano Barbacid
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Reduction of artifacts in T2 -weighted PROPELLER in high-field preclinical imaging.

Authors:  Prachi Pandit; Yi Qi; Kevin F King; G Allan Johnson
Journal:  Magn Reson Med       Date:  2010-10-06       Impact factor: 4.668

3.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

4.  Cancer: Clinical trials unite mice and humans.

Authors:  Leisa Johnson
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

5.  Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.

Authors:  Julian Carretero; Takeshi Shimamura; Klarisa Rikova; Autumn L Jackson; Matthew D Wilkerson; Christa L Borgman; Matthew S Buttarazzi; Benjamin A Sanofsky; Kate L McNamara; Kathleyn A Brandstetter; Zandra E Walton; Ting-Lei Gu; Jeffrey C Silva; Katherine Crosby; Geoffrey I Shapiro; Sauveur-Michel Maira; Hongbin Ji; Diego H Castrillon; Carla F Kim; Carlos García-Echeverría; Nabeel Bardeesy; Norman E Sharpless; Neil D Hayes; William Y Kim; Jeffrey A Engelman; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

6.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

Authors:  Karl A Merrick; Sandra Morandell; Chang-Qi Zhu; Ian G Cannell; Christian J Braun; Robert A Grant; Eleanor R Cameron; Ming-Sound Tsao; Michael T Hemann; Michael B Yaffe
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

7.  Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.

Authors:  Kate D Sutherland; Ji-Ying Song; Min Chul Kwon; Natalie Proost; John Zevenhoven; Anton Berns
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

8.  Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

Authors:  Youngtae Jeong; Ngoc T Hoang; Alexander Lovejoy; Henning Stehr; Aaron M Newman; Andrew J Gentles; William Kong; Diana Truong; Shanique Martin; Aadel Chaudhuri; Diane Heiser; Li Zhou; Carmen Say; Justin N Carter; Susan M Hiniker; Billy W Loo; Robert B West; Philip Beachy; Ash A Alizadeh; Maximilian Diehn
Journal:  Cancer Discov       Date:  2016-09-23       Impact factor: 39.397

Review 9.  Lung stem and progenitor cells in tissue homeostasis and disease.

Authors:  Kristen T Leeman; Christine M Fillmore; Carla F Kim
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

10.  Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.

Authors:  Ning Yin; Yi Liu; Andras Khoor; Xue Wang; E Aubrey Thompson; Michael Leitges; Verline Justilien; Capella Weems; Nicole R Murray; Alan P Fields
Journal:  Cancer Cell       Date:  2019-08-01       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.